Background and Purpose: The purpose of the present study was to clarify the difference in the infarct topography on diffusion-weighted image (DWI) and cardiac and aortic findings on transesophageal echocardiography (TEE) in stroke patients with different embolic sources. Methods: We studied 270 consecutive patients with acute ischemic stroke who had DWI-documented cortical or subcortical infarcts without significant stenosis of the cerebral arteries. As embolic sources, cardiac diseases, right-to-left shunt diseases and an aortic arch atheroma ≧4.0 mm in thickness were identified using various diagnostic tools including TEE. Results: Seventy-eight (29%) patients had multiple embolic sources. Large infarcts were common in patients in whom cardiac disease was the only embolic source and uncommon in patients in whom aortic atheroma was the only embolic source (p < 0.0001). Vertebrobasilar infarcts were relatively common in patients only having aortic atheromas. Atrial septal aneurysms were more common in patients with a right-to-left shunt than in those with a shunt plus other embolic sources (p = 0.0036). Unique characteristics of the arch atheroma (mobile plaque, extension to branches, or ulcer formation; p < 0.0001) as well as small or moderate-sized infarcts (p = 0.0004) were more common in patients with arch atheromas as the only embolic source than in those with atheromas plus other embolic sources. Conclusions: Embolic stroke patients often have multiple embolic sources. The present study suggests the possibility that embolic stroke has unique clinical features depending on its source. DWI and TEE findings might be helpful in characterizing cardiogenic, paradoxical and aortogenic brain embolism.

1.
Yonemura K, Kimura K, Minematsu K, Uchino M, Yamaguchi T: Small centrum ovale infarcts on diffusion-weighted magnetic resonance imaging. Stroke 2002;33:1541–1544.
2.
Warach S, Gaa J, Siewert B, Wielopolski P, Edelman RR: Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol 1995;37:231–241.
3.
Pop G, Sutherland GR, Koudstaal PJ, Sit TW, de Jong G, Toelandt JRTC: Transesophageal echocardiography in the detection of intracardiac embolic sources in patients with transient ischemic attacks. Stroke 1990;21:560–565.
4.
Cujec B, Polasek P, Voll C, Shuaib A: Transesophageal echocardiography in the detection of potential cardiac sources of embolism in stroke patients. Stroke 1991;22:727–733.
5.
Toyoda K, Yasaka M, Nagata S, Yamaguchi T: Aortogenic embolic stroke: a transesophageal echocardiographic approach. Stroke 1992;23:1056–1061
6.
Amarenco P, Duyckaerts C, Tzourio C, Henin D, Bousser M-G, Hauw J-J: The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med 1992;326:221–225
7.
Amarenco P, Cohen A, Tzourio C, Bertrand B, Hommel M, Besson G, Chauvel C, Touboul P-J, Bousser M-G: Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994;331:1474–1479
8.
Petty GW, Khandheria BK, Chu CP, Sicks JD, Whisnant JP: Patent foramen ovale in patients with cerebral infarction. A transesophageal echocardiographic study. Arch Neurol 1997;54:819–822.
9.
Kristensen B, Malm J, Carlberg B, Stegmayr B, Backman C, Fagerlund M, Olsson T: Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in northern Sweden. Stroke 1997;28:1702–1709.
10.
Mugge A, Kuhn H, Nikutta P, Grote J, Lopez JAG, Daniel WG: Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: identification of a subgroup of patients at increased embolic risk. J Am Coll Cardiol 1994;23:599–607.
11.
Albers GW, Caplan LR, Easton JD, Fayad PB, Mohr JP, Saver JL, Sherman DG: Transient ischemic attack – proposal for a new definition. N Engl J Med 2002;347:1713–1716.
12.
Adams HP, Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE: 3rd, and the TOAST investigators. Classification of subtype of acute ischemic stroke. Definition for use in a multicenter clinical trial. Stroke 1993;24:35–41.
13.
Fatkin D, Herbert E, Feneley MP: Hematologic correlates of spontaneous echo contrast in patients with atrial fibrillation and implications for thromboembolic risk. Am J Cardiol 1994;73:672–676.
14.
Ueno Y, Kimura K, Iguchi Y, Shibazaki K, Inoue T, Hattori N, Urabe T: Mobile aortic plaques are a cause of multiple brain infarcts seen on diffusion-weighted imaging. Stroke 2007;38:2470–2476.
15.
Stone DA, Hawke MW, LaMonte M, Kittner SJ, Acosta J, Corretti M, Sample C, Price TR, Plotnick GD: Ulcerated atherothrombotic plaques in thoracic aorta are associated with cryptogenic stroke: a multiplane transesophageal echocardiographic study. Am Heart J 1995;130:105–108.
16.
Fujimoto S, Yasaka M, Otsubo R, Oe H, Nagatsuka K, Minematsu K: Aortic arch atherosclerotic lesions and the recurrence of ischemic stroke. Stroke 2004;35:1426–1429.
17.
Mugge A, Daniel WG, Angermann C, Spes C, Khandheria BK, Kronzon I, Freedberg RS, Keren A, Dennig K, Engberding R, Sutherland GR, Vered Z, Erbel R, Visser CA, Lindert O, Hausmann D, Wenzlaff P: Atrial septal aneurysm in adult patients: a multicenter study using transesophageal echocardiography. Circulation 1995;91:2785–2792.
18.
Mentel T, Pasierski T, Szwed H, Baranska-Gieruszczak M, Czlonkowska A: Transesophageal echocardiographic findings in patients with anterior and posterior circulation infarcts. Acta Neurol Scand 1998;97:63–67.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.